Jeong-ju W. Yoo

Puch'on, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 219 publications

A Novel Anchoring Catheter Improves the Success, Efficiency, and Satisfaction of Paracentesis in Refractory Ascites: A Multicenter Randomized Crossover Trial.

A Novel Anchoring Catheter Improves the Success, Efficiency, and Satisfaction of Paracentesis in Refractory Ascites: A Multicenter Randomized Crossover Trial.

Journal: Journal of gastroenterology and hepatology

Published: August 15, 2026

Tirzepatide-Associated Severe Hepatocellular Injury: A Case Report and Diagnostic Considerations.

Tirzepatide-Associated Severe Hepatocellular Injury: A Case Report and Diagnostic Considerations.

Journal: Diagnostics (Basel, Switzerland)

Published: May 18, 2026

KASL clinical practice guidelines for management of chronic hepatitis B Endorsed by the East Asia Liver Alliance (EALA).

KASL clinical practice guidelines for management of chronic hepatitis B Endorsed by the East Asia Liver Alliance (EALA).

Journal: Clinical and molecular hepatology

Published: May 09, 2026

Spontaneous intracerebral hemorrhage associated with lenvatinib in advanced hepatocellular carcinoma without conventional risk factors: a case report literature review.

Spontaneous intracerebral hemorrhage associated with lenvatinib in advanced hepatocellular carcinoma without conventional risk factors: a case report literature review.

Journal: Frontiers in oncology

Published: May 08, 2026

Toward a future role for liver biopsy in HCC: literature evidence and survey-based perspectives from Korean experts.

Toward a future role for liver biopsy in HCC: literature evidence and survey-based perspectives from Korean experts.

Journal: Journal of liver cancer

Published: May 04, 2026

Diagnostic Performance of Serum-Ascites Albumin Gradient: A Systematic Review and Meta-Analysis.

Diagnostic Performance of Serum-Ascites Albumin Gradient: A Systematic Review and Meta-Analysis.

Journal: Gut and liver

Published: April 16, 2026

Divergent risk profiles for cause-specific mortality in MASLD and MetALD: a nationwide population-based study.

Divergent risk profiles for cause-specific mortality in MASLD and MetALD: a nationwide population-based study.

Journal: Frontiers in medicine

Published: March 17, 2026

Liver fibrosis burden and risk of incident arrhythmia in metabolic dysfunction-associated steatotic liver disease.

Liver fibrosis burden and risk of incident arrhythmia in metabolic dysfunction-associated steatotic liver disease.

Journal: Scientific reports

Published: March 06, 2026

KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications 2026.

KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications 2026.

Journal: Clinical and molecular hepatology

Published: March 04, 2026

Machine learning-based prediction of hepatocellular carcinoma risk in steatotic liver disease: A nationwide cohort study.

Machine learning-based prediction of hepatocellular carcinoma risk in steatotic liver disease: A nationwide cohort study.

Journal: PloS one

Published: February 12, 2026

Efficacy and Long-Term Outcomes of Direct-Acting Antivirals in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.

Efficacy and Long-Term Outcomes of Direct-Acting Antivirals in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.

Journal: Gut and liver

Published: January 10, 2026

High Cardiometabolic Risk Burden Predicts Adverse Outcomes in Patients with MASLD-Related Hepatocellular Carcinoma.

High Cardiometabolic Risk Burden Predicts Adverse Outcomes in Patients with MASLD-Related Hepatocellular Carcinoma.

Journal: Gut and liver

Published: November 30, 2025

Showing 1-12 of 219

Last Updated: 09/26/2026